IIM
MRNA icon

INTECH Investment Management’s Moderna MRNA Stock Holding History

INTECH Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$319K Sell
4,561
-14,965
-77% -$774K ﹤0.01% 1549
2026
Q1 		$992K Buy
19,526
+9,508
+95% +$444K 0.01% 1025
2025
Q4 		$295K Buy
+10,018
New +$272K ﹤0.01% 1772
2025
Q1 		– Sell
-5,956
Closed -$248K – 2547
2024
Q4 		$248K Buy
+5,956
New +$285K ﹤0.01% 1927
2024
Q2 		– Sell
-330,805
Closed -$35.3M – 1120
2024
Q1 		$35.3M Buy
330,805
+305,609
+1,213% +$30.8M 0.5% 40
2023
Q4 		$2.51M Sell
25,196
-77,684
-76% -$6.53M 0.04% 310
2023
Q3 		$10.6M Sell
102,880
-233,205
-69% -$26M 0.16% 148
2023
Q2 		$40.8M Buy
336,085
+266,888
+386% +$35.6M 0.42% 62
2023
Q1 		$10.6M Buy
69,197
+12,599
+22% +$2.08M 0.09% 268
2022
Q4 		$10.2M Sell
56,598
-49,423
-47% -$8.08M 0.08% 291
2022
Q3 		$12.5M Sell
106,021
-162,236
-60% -$24.6M 0.09% 250
2022
Q2 		$38.3M Buy
+268,257
New +$38.3M 0.22% 127

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

INTECH Investment Management's MRNA Position: Q2 2026 in Review

INTECH Investment Management reduced its Moderna (MRNA) stake by 77% in Q2 2026, selling an estimated $774K and leaving 4,561 shares worth $319K. The position accounts for ﹤0.01% of the portfolio, ranked #1549.

INTECH Investment Management first reported a position in MRNA in Q2 2022 and has held it in 12 quarters since. The position peaked at $40.8M in Q2 2023. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • INTECH Investment Management held 4,561 shares of Moderna worth $319K as of Q2 2026.
  • INTECH Investment Management sold 14,965 Moderna shares in Q2 2026, an estimated $774K.
  • Moderna made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1549 holding.
  • INTECH Investment Management first reported a position in Moderna in Q2 2022 and has held it in 12 quarters since.
  • INTECH Investment Management's Moderna position peaked at $40.8M in Q2 2023.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.